The NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease in three independent populations

Atherosclerosis

Volumn 219, Issue 1, 2011, Pages 200-204

  Vogel, Ulla ^a,b,c   Jensen, Majken K ^d   Due, Karen Margrete ^e   Rimm, Eric B ^d,f   Wallin, Håkan ^a   Nielsen, Michael R S ^e   Pedersen, Anne Pernille T ^e   Tjønneland, Anne ^g   Overvad, Kim ^e,h  

^a NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c ROSKILDE UNIVERSITY   (Denmark)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^h AARHUS UNIVERSITY   (Denmark)

Author keywords

Inflammation; NF B; Polymorphism; Population based

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INDEL MUTATION; INFLAMMATION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; NFKB 1 GENE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; CORONARY DISEASE; DENMARK; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK; SEQUENCE DELETION; UNITED STATES;

EID: 80055013127     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.06.018     Document Type: Article

References (27)

1. Fontaine-Bisson B., Wolever T.M., Connelly P.W., Corey P.N., El-Sohemy A. NF-kappaB -94Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations. Atherosclerosis 2009, 204:465-470.
2. Pereira S.G., Oakley F. Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol 2008, 40:1425-1430.
3. Cao S., Zhang X., Edwards J.P., Mosser D.M. NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem 2006, 281:26041-26050.
4. Lin L., DeMartino G.N., Greene W.C. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 1998, 92:819-828.
5. Karban A.S., Okazaki T., Panhuysen C.I., et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004, 13:35-45.
6. Park J.Y., Farrance I.K., Fenty N.M., et al. NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensives. Am J Physiol Heart Circ Physiol 2007, 293:H2320-H2327.
7. Tjonneland A., Olsen A., Boll K., et al. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 2007, 35:432-441.
8. Joensen A.M., Jensen M.K., Overvad K., et al. Predictive values of acute coronary syndrome discharge diagnoses differed in the Danish National Patient Registry. J Clin Epidemiol 2009, 62:188-194.
9. Colditz G.A., Manson J.E., Hankinson S.E. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 1997, 6:49-62.
10. Rimm E.B., Giovannucci E.L., Stampfer M.J., et al. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992, 135:1114-1126.
11. Rimm E.B., Giovannucci E.L., Willett W.C., et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991, 338:464-468.
12. Prentice R.L., Kalbfleisch J.D., Peterson A.V., et al. The analysis of failure times in the presence of competing risks. Biometrics 1978, 34:541-554.
13. Jensen M.K., Rimm E.B., Mukamal K.J., et al. The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations. Eur Heart J 2009, 30:1584-1589.
14. Vogel U., Segel S., Dethlefsen C., et al. PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes. BMC Med Genet 2009, 10:52.
15. Jensen M.K., Rimm E.B., Rader D., et al. S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies. Am Heart J 2009, 157:384-390.
16. Vogel U., Segel S., Dethlefsen C., et al. Associations between COX-2 polymorphisms, blood cholesterol and risk of acute coronary syndrome. Atherosclerosis 2010, 209:155-162.
17. Pai J.K., Pischon T., Ma J., et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004, 351:2599-2610.
18. Vangsted A.J., Klausen T.W., Ruminski W., et al. The polymorphism IL-1beta T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT. Bone Marrow Transplant 2009, 43:539-545.
19. Kalbfleisch J.D., Lawless J.F.J.F. Likelihood analysis of multi-state models for disease incidence and mortality. Stat Med 1988, 7:149-160.
20. Perkins N.D. Integrating cell-signalling pathways with NF-kappa B and IKK function. Nat Rev Mol Cell Biol 2007, 8:49-62.
21. de Winther M.P., Kanters E., Kraal G., Hofker M.H. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005, 25:904-914.
22. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225-260.
23. Cha-Molstad H., Agrawal A., Zhang D., Samols D., Kushner I. The Rel family member P50 mediates cytokine-induced C-reactive protein expression by a novel mechanism. J Immunol 2000, 165:4592-4597.
24. Pai J.K., Mukamal K.J., Rexrode K.M., Rimm E.B. C-reactive protein (CRP) gene polymorphisms CRP levels, and risk of incident coronary heart disease in two nested case-control studies. PLoS One 2008, 3:e1395.
25. Elliott P., Chambers J.C., Zhang W., et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009, 302:37-48.
26. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
27. Schunkert H., Konig I.R., Kathiresan S., et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011.